Investing.com — Roche’s experimental Parkinson’s disease drug, prasinezumab, failed to meet its primary objective in a mid-stage trial. The Swiss...
Read moreInvesting.com – Cintas (NASDAQ: CTAS) reported fourth quarter EPS of $1.09, $0.08 better than the analyst estimate of $1.01. Revenue...
Read moreInvesting.com — Palantir Technologies Inc . (NASDAQ:PLTR) stock climbed 3% following a new coverage initiation by UBS and news of...
Read moreInvesting.com — Shares of Omeros (NASDAQ:OMER) Corporation surged 73% early Thursday following the announcement of positive survival data from an...
Read moreInvesting.com — Shares of Trio Petroleum Corp skyrocketed by 300% early Thursday following the company’s announcement of a non-binding Letter...
Read moreInvesting.com – Turkey stocks were lower after the close on Thursday, as losses in the Telecoms, Tourism and Banking sectors...
Read moreThursday’s trading session is witnessing significant movements in mega-cap and large-cap stocks, with companies like Accenture Ltd (NYSE:ACN) and Apple...
Read moreBy Kate Abnett and Anastasiia Malenko BRUSSELS (Reuters) – Ukraine could consider continued transit of Russian gas on the condition...
Read more(Reuters) -Accenture beat Wall Street estimates for first-quarter revenue and profit on Thursday, on the back of growing demand for...
Read more(Reuters) – The suspect in the killing of UnitedHealth Group (NYSE:UNH) executive Brian Thompson is due to appear in a...
Read moreCopyright © 2026 proudforprofits.com | All Rights Reserved